Off the wire
• China warns officials against extravagance ahead of major festivals  • Judicial authorities promise better legal environment for commerce  • Brexit to raise chances of Scottish independence: William Hague  • 1st LD-Writethru: Hyenas lived in SW China 4 mln years ago, research confirms  • 769 bln yuan invested in developing western China in 2015  • China braces for record passengers in upcoming "Chunyun"  • China cuts coal-fired power price  • Interview: Russian expert praises anti-crisis measures adopted in China's key economic meeting  • Terrorist suspect of beheading his boss kills himself in jail in France  • Lawmakers call for greater supervision, penalty after IPO reform  
You are here: 　 Home

Dafalgan Pediatrie 30mg/ml in many EU countries recalled

Xinhua, December 23, 2015 Adjust font size:

Luxembourg Ministry of Health has issued an alert against some vials of "Dafalgan Pediatrie" which may contain polyurethane.

This is one of the most used drugs in pediatrics in many European countries, especially in Belgium, France and Luxembourg, confirmed the ministry to Xinhua on Wednesday.

According to the ministry, polyurethane particles have been found in packaging equipment of some batches of drugs "Dafalgan Pediatrics 30mg/ml."

A possible product contamination can not be excluded and the drug of mentioned batches are to be returned to the pharmacy, it said.

According to a ministry statement, the firm Bristol-Myers Squibb Belgium has recalled the medicine Dafalgan Pediatrie 30mg/ml for "reasons of non-conformity." Enditem